Invention Grant
- Patent Title: Compounds for the treatment of metabolic disorders
-
Application No.: US13920579Application Date: 2013-06-18
-
Publication No.: US09133073B2Publication Date: 2015-09-15
- Inventor: Shalini Sharma
- Applicant: WELLSTAT THERAPEUTICS CORPORATION
- Applicant Address: US MD Gaithersburg
- Assignee: Wellstat Therapeutics Corporation
- Current Assignee: Wellstat Therapeutics Corporation
- Current Assignee Address: US MD Gaithersburg
- Agent Lewis J. Kreisler
- Main IPC: A01N37/10
- IPC: A01N37/10 ; C07B41/12 ; A61K31/165 ; A61K31/192 ; A61K31/216 ; A61K31/235 ; A61K31/41 ; A61K31/4196 ; A61K31/44 ; A61K31/445 ; A61K31/535 ; A61K31/54 ; C07C59/68 ; C07C59/90 ; C07C69/738 ; C07C217/22 ; C07C233/31 ; C07C233/47 ; C07C235/78 ; C07C235/84 ; C07C259/06 ; C07C323/52 ; C07C323/59 ; C07D213/30 ; C07D249/10 ; C07D249/12 ; C07D257/04 ; C07D333/16 ; C07C67/47 ; C07C209/68 ; C07D213/55 ; C07D333/24
Abstract:
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Public/Granted literature
- US20130281705A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Public/Granted day:2013-10-24
Information query
